Saturday, February 5, 2011
Chronic Kidney Disease Pipeline Assessment and Market Forecasts to 2016
GlobalData's analysis suggests that the global chronic kidney disease (CKD) market was worth $13.3 billion in 2009. It is forecast to grow at a Compound Annual Growth Rate (CAGR) of 5.9% for the next seven years to reach $19.8 billion by 2016. The market is expected to be driven by an increase in prevalence and the treatment seeking population and in part is due to the introduction of Feraheme to treat anemia related to CKD. The global market revenues are expected to increase due to the
